Raloxifene in Treatment of Schizophrenia and Schizoaffective Disorder
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the efficacy of raloxifene compared to placebo, as
add-on to anti-psychotics in the treatment of post menopausal patients with schizophrenia.